Allogeneic stem cell transplantation for patients with myelodysplastic syndromes-Reference-Cited by-同舟云学术

Allogeneic stem cell transplantation for patients with myelodysplastic syndromes

Published:2022-10-28 Issue:2 Volume:98 Page:322-337
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Vittayawacharin Pongthep¹²^ORCID,Kongtim Piyanuch¹^ORCID,Ciurea Stefan O.¹

Affiliation:

1. Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine University of California Irvine Irvine California USA

2. Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital Mahidol University Bangkok Thailand

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26763

Reference93 articles.

1. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

2. Unraveling the Molecular Pathophysiology of Myelodysplastic Syndromes

3. AulettaJ.J.KJ ChenM. ShawB.E.Current use and outcome of hematopoietic stem cell transplantation: CIBMTR US summary slides.2021.

4. International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes

5. Time-Dependent Prognostic Scoring System for Predicting Survival and Leukemic Evolution in Myelodysplastic Syndromes

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative analysis of immunological changes following realgar and arsenic trioxide treatments in a murine model of myelodysplastic syndrome;Immunopharmacology and Immunotoxicology;2024-05-03

2. Comparison of Melphalan Dose in Patients with Myelodysplastic Syndrome Undergoing Allogeneic Transplantation with Reduced-Intensity Conditioning;Transplantation and Cellular Therapy;2024-05

3. Role of reactive oxygen species in myelodysplastic syndromes;Cellular & Molecular Biology Letters;2024-04-14

4. Pulmonary infection associated with immune dysfunction is associated with poor prognosis in patients with myelodysplastic syndrome accompanied by TP53 abnormalities;Frontiers in Oncology;2023-11-30

5. Hematopoietic Cell Transplantation and Cellular Therapy in Myelodysplastic Syndromes;Cancer Consult;2023-11-18